Published in Dis Colon Rectum on January 01, 2002
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol (2015) 1.73
Does a learning curve exist in endorectal two-dimensional ultrasound accuracy? Tech Coloproctol (2011) 1.41
Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer. Radiat Oncol J (2012) 1.16
Local staging of rectal cancer: the current role of MRI. Eur Radiol (2006) 1.09
Rectal cancer staging: Correlation between the evaluation with radial echoendoscope and rigid linear probe. Endosc Ultrasound (2014) 1.07
Outcomes for early rectal cancer managed with transanal endoscopic microsurgery: a 5-year follow-up study. Surg Endosc (2006) 1.05
Metabolomic characterization of human rectal adenocarcinoma with intact tissue magnetic resonance spectroscopy. Dis Colon Rectum (2009) 1.04
Current trends in staging rectal cancer. World J Gastroenterol (2011) 1.02
Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy. Int J Colorectal Dis (2009) 0.98
How useful is rectal endosonography in the staging of rectal cancer? World J Gastroenterol (2010) 0.97
The Use of PET-CT in the Assessment of Patients with Colorectal Carcinoma. Int J Surg Oncol (2011) 0.94
Preoperative staging of rectal carcinoma by endorectal ultrasound: is there a learning curve? Int J Colorectal Dis (2007) 0.93
Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference. Surg Endosc (2015) 0.93
Accuracy of endorectal ultrasonography in staging locally advanced rectal cancer after preoperative chemoradiation. Surg Endosc (2008) 0.92
Evolving treatment strategies for colorectal cancer: a critical review of current therapeutic options. World J Gastroenterol (2014) 0.89
Rectal cancer: how accurate can imaging predict the T stage and the circumferential resection margin? Int J Colorectal Dis (2003) 0.89
Endorectal ultrasonography versus phased-array magnetic resonance imaging for preoperative staging of rectal cancer. World J Gastroenterol (2008) 0.88
Preoperative staging of patients with rectal tumors suitable for transanal endoscopic microsurgery (TEM): comparison of endorectal ultrasound and histopathologic findings. Surg Endosc (2009) 0.87
Clinical significance of magnetic resonance imaging findings in rectal cancer. World J Radiol (2011) 0.86
The accuracy of multi-detector row computerized tomography in staging rectal cancer compared to endoscopic ultrasound. Saudi J Gastroenterol (2013) 0.86
The value of endosonographic rectal carcinoma staging in routine diagnostics: a 10-year analysis. Surg Endosc (2004) 0.85
Multimodal imaging evaluation in staging of rectal cancer. World J Gastroenterol (2014) 0.85
Endorectal ultrasound: its role in the diagnosis and treatment of rectal cancer. Clin Colon Rectal Surg (2008) 0.84
The role of 3-D endorectal ultrasound in rectal cancer: our experience. Int Surg (2014) 0.83
When is local excision appropriate for "early" rectal cancer? Surg Today (2013) 0.83
P53 abnormalities and outcomes in colorectal cancer: a systematic review. Br J Cancer (2005) 0.81
Intensity of tumor budding as an index for the malignant potential in invasive rectal carcinoma. Cancer Res Treat (2005) 0.81
Multidisciplinary treatment of rectal cancer in 2014: where are we going? World J Gastroenterol (2014) 0.80
Learning curve of endorectal ultrasonography in preoperative staging of rectal carcinoma. Mol Clin Oncol (2014) 0.80
The learning curve for endorectal ultrasonography in rectal cancer staging. Surg Endosc (2010) 0.79
Increased detection rate and potential prognostic impact of disseminated tumor cells in patients undergoing endorectal ultrasound for rectal cancer. Int J Colorectal Dis (2006) 0.79
Replacing Transanal Excision with Transanal Endoscopic Microsurgery and/or Transanal Minimally Invasive Surgery for Early Rectal Cancer. Clin Colon Rectal Surg (2015) 0.78
A survey on the impact of operation volume on rectal cancer management. J Korean Med Sci (2007) 0.78
Increasing late stage colorectal cancer and rectal cancer mortality demonstrates the need for screening: a population based study in Ireland, 1994-2010. BMC Gastroenterol (2014) 0.77
Endoscopic ultrasonography (EUS) in the staging of malignancy. Cancer Imaging (2004) 0.75
MRI in local staging of rectal cancer: an update. Diagn Interv Radiol (2014) 0.75
Preoperative radiotherapy in carcinoma rectum. Indian J Surg Oncol (2012) 0.75
The shortcomings of radiologic staging for rectal cancer and the impact on the treatment plan. Saudi J Gastroenterol (2013) 0.75
A scoring system basing pathological parameters to predict regional lymph node metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer: implication for local excision. Oncotarget (2016) 0.75
Role of endoscopic ultrasonography in the loco-regional staging of patients with rectal cancer. World J Gastrointest Endosc (2015) 0.75
When less is more, when less is less: local excision in early rectal cancer. Gastrointest Cancer Res (2009) 0.75
Multimodal Assessments Are Needed for Restaging after Neoadjunvant Chemoradiation Therapy in Rectal Cancer Patients. Cancer Res Treat (2015) 0.75
Endorectal ultrasound does not reliably identify patients with uT3 rectal cancer who can avoid neoadjuvant chemoradiotherapy. Int J Colorectal Dis (2013) 0.75
Radical surgery for early colorectal cancer--anachronism or oncologic necessity? Int J Colorectal Dis (2008) 0.75
Development of a cost-effective system for digital off-line analysis of transrectal ultrasound. Surg Endosc (2005) 0.75
Rectal endosonography: just how good are we at its interpretation? Int J Colorectal Dis (2009) 0.75
Confocal chromolaser endomicroscopy: a supplemental diagnostic tool prior to transanal endoscopic microsurgery of rectal tumors? Int J Colorectal Dis (2009) 0.75
Usefulness of anorectal and endovaginal 3D ultrasound in the evaluation of sphincter and pubovisceral muscle defects using a new scoring system in women with fecal incontinence after vaginal delivery. Int J Colorectal Dis (2016) 0.75
Predictors for regional lymph node metastasis in T1 rectal cancer: a population-based SEER analysis. Surg Endosc (2016) 0.75
Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology (2005) 3.58
Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum (2006) 3.43
Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst (2005) 2.91
Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg (2007) 2.55
Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol (2009) 2.50
Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet (2011) 2.33
Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery (2009) 2.29
Sacral nerve stimulation for fecal incontinence: results of a 120-patient prospective multicenter study. Ann Surg (2010) 2.29
Multicenter Evaluation of Rectal cancer ReImaging pOst Neoadjuvant (MERRION) Therapy. Ann Surg (2014) 2.28
Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol (2008) 2.27
Percutaneous drainage of colonic diverticular abscess: is colon resection necessary? Dis Colon Rectum (2013) 2.22
Sacral spinal nerve stimulation for faecal incontinence: multicentre study. Lancet (2004) 2.17
Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg (2003) 2.16
Primary perineal wound closure after preoperative radiotherapy and abdominoperineal resection has a high incidence of wound failure. Dis Colon Rectum (2005) 2.04
A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum (2003) 2.04
cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol (2008) 1.93
Operative outcomes beyond 30-day mortality: colorectal cancer surgery in oldest old. Ann Surg (2011) 1.93
Rectus flap reconstruction decreases perineal wound complications after pelvic chemoradiation and surgery: a cohort study. Ann Surg Oncol (2005) 1.92
The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg (2006) 1.90
Assessment of ACS NSQIP's predictive ability for adverse events after major cancer surgery. Ann Surg Oncol (2010) 1.88
Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer (2002) 1.87
Quality of life after subtotal colectomy for slow-transit constipation: both quality and quantity count. Dis Colon Rectum (2003) 1.84
Single port laparoscopic right hemicolectomy with D3 dissection for advanced colon cancer. World J Gastroenterol (2010) 1.77
Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol (2004) 1.74
Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg (2002) 1.66
Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg (2002) 1.65
Surgical therapy for anorectal melanoma. J Am Coll Surg (2003) 1.65
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg (2005) 1.64
Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resection. Dis Colon Rectum (2010) 1.64
Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection? Ann Surg Oncol (2004) 1.62
Extranodal follicular dendritic cell sarcoma: clinical, pathologic, and histogenetic characteristics of an underrecognized disease entity. Virchows Arch (2006) 1.62
Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol (2008) 1.61
Magnetic anal sphincter augmentation for the treatment of fecal incontinence: a preliminary report from a feasibility study. Dis Colon Rectum (2010) 1.61
Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis (2003) 1.59
Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol (2004) 1.58
Effects of obesity in rectal cancer surgery. J Am Coll Surg (2010) 1.56
The status of radical proctectomy and sphincter-sparing surgery in the United States. Dis Colon Rectum (2007) 1.55
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol (2008) 1.54
Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol (2003) 1.54
Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Dis Colon Rectum (2008) 1.53
Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer (2008) 1.53
Developing a research agenda for the American Society of Colon and Rectal Surgeons: results of a delphi approach. Dis Colon Rectum (2009) 1.52
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol (2002) 1.50
Colorectal procedures: what proportion is performed by American board of colon and rectal surgery-certified surgeons? Dis Colon Rectum (2010) 1.49
T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg (2005) 1.49
Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection. Ann Surg (2009) 1.48
Long-term results of local excision for rectal cancer. Ann Surg (2002) 1.44
Feasibility of ex vivo FDG PET of the colon. Radiology (2009) 1.43
Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys (2005) 1.40
Career options in colon and rectal surgery. Clin Colon Rectal Surg (2006) 1.38
Evaluation of family history information within clinical documents and adequacy of HL7 clinical statement and clinical genomics family history models for its representation: a case report. J Am Med Inform Assoc (2010) 1.37
The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum (2005) 1.37
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg (2004) 1.32
Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum (2005) 1.26
A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol (2006) 1.26
Fistula-associated anal adenocarcinoma: good results with aggressive therapy. Dis Colon Rectum (2008) 1.24
Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer. Ann Surg (2011) 1.24
Carcinoid of the rectum risk stratification (CaRRs): a strategy for preoperative outcome assessment. Ann Surg Oncol (2007) 1.24
Long-term results of anterior sphincteroplasty. Dis Colon Rectum (2004) 1.23
Lymph node metastasis in T1 adenocarcinoma of the colon and rectum. J Gastrointest Surg (2004) 1.21
Squamous-cell carcinoma of the rectum: a rare but curable tumor. Dis Colon Rectum (2007) 1.20
Long-term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum (2009) 1.20
Long-term efficacy and safety of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum (2011) 1.19
Measuring fecal incontinence. Dis Colon Rectum (2003) 1.18
Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. J Clin Oncol (2005) 1.16
Management of recurrent rectal prolapse: surgical approach influences outcome. Dis Colon Rectum (2006) 1.16
Treatment of complex anal fistulas with the collagen fistula plug. Dis Colon Rectum (2008) 1.16
Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance. Hum Pathol (2008) 1.14
Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype. J Surg Oncol (2009) 1.13
Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum (2013) 1.12
Transanal endoscopic microsurgery versus conventional transanal excision for patients with early rectal cancer. Ann Surg (2009) 1.12
Salvage radical surgery after failed local excision for early rectal cancer. Dis Colon Rectum (2002) 1.12
Treatment of transsphincteric anal fistulas by endorectal advancement flap or collagen fistula plug: a comparative study. Dis Colon Rectum (2009) 1.09
Endorectal ultrasound in the preoperative evaluation of rectal cancer. Clin Colorectal Cancer (2004) 1.07
Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol (2006) 1.07
Major cancer surgery in the elderly: results from the American College of Surgeons National Surgical Quality Improvement Program. Ann Surg (2010) 1.07
Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy. Am J Surg Pathol (2002) 1.06
Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen. Clin Cancer Res (2004) 1.06
Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum (2008) 1.06
Does enrollment in cancer trials improve survival? J Am Coll Surg (2013) 1.06
Symptom control in patients with locally recurrent rectal cancer. Ann Surg Oncol (2003) 1.05
Metabolomic characterization of human rectal adenocarcinoma with intact tissue magnetic resonance spectroscopy. Dis Colon Rectum (2009) 1.04
Transanal endoscopic microsurgery resection of rectal tumors: outcomes and recommendations. Dis Colon Rectum (2010) 1.04